Phase II study of vinflunine in malignant pleural mesothelioma.

Phase II study of vinflunine in malignant pleural mesothelioma.

PURPOSE: Malignant pleural mesothelioma (MPM) is a disease of increasing incidence for which treatment options are limited. This study reports the clinical efficacy data for vinflunine, a novel microtubule inhibitor, in MPM. PATIENTS AND METHODS: Patients with a histologically confirmed diagnosis o...

Full description

Bibliographic Details
Main Authors:	Talbot, D, Margery, J, Dabouis, G, Dark, G, Taylor, H, Boussemart, H, Cadic, V, Pinel, M, Rivière, A, Ollivier, L, Ruffié, P
Format:	Journal article
Language:	English
Published:	2007

Similar Items

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
by: Bibby, A, et al.
Published: (2016)

BTS guideline for the investigation and management of malignant pleural mesothelioma
by: Woolhouse, I, et al.
Published: (2018)

RANDOM WALK-BASED AUTOMATED SEGMENTATION FOR THE PROGNOSIS OF MALIGNANT PLEURAL MESOTHELIOMA
by: Chen, M, et al.
Published: (2011)

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
by: Woolhouse, I, et al.
Published: (2018)

Computer-assisted volumetric tumour assessment for the evaluation of patient response in malignant pleural mesothelioma
by: Chen, M
Published: (2011)

Pleural abnormalities predating the development of mesothelioma
by: Hassan, M, et al.
Published: (2017)

The association between pleural fluid exposure and survival in pleural mesothelioma
by: Asciak, R, et al.
Published: (2021)

Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma.
by: Morel, A, et al.
Published: (2010)

Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052).
by: O'Brien, M, et al.
Published: (2013)

Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments
by: Kanellakis, NI, et al.
Published: (2020)

Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial
by: Brims, F, et al.
Published: (2019)

Phase 1 study of HSP90 inhibitor ganetespib with pemetrexed and cisplatin/carboplatin chemotherapy for pleural mesothelioma
by: Fennell, D, et al.
Published: (2018)

Pleural diseases: saline irrigation in pleural infection, epidemiology of pneumothorax, and bevacizumab in mesothelioma
by: Corcoran, J, et al.
Published: (2017)

Computer-aided volumetric assessment of malignant pleural mesothelioma on CT using a random walk-based method.
by: Chen, M, et al.
Published: (2017)

18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma
by: Hall, DO, et al.
Published: (2018)

Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma
by: Lim, E, et al.
Published: (2020)

Human mesothelioma cell lines developed from malignant pleural effusions as tools to develop novel therapies and guide personalised medicine
by: Kanellakis, N, et al.
Published: (2018)

Shining light on pleural biopsy in mesothelioma: Is it time to get “smart”?
by: Bedawi, E, et al.
Published: (2019)

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial
by: Clive, A, et al.
Published: (2016)

Anterior cingulotomy improves malignant mesothelioma pain and dyspnoea.
by: Pereira, E, et al.
Published: (2014)

Pleural disease (excluding malignancy)
by: Davies, H, et al.
Published: (2008)

Chemotherapy does not increase the risk of pleural infection in patients managed with an indwelling pleural catheter for malignant pleural effusion
by: Morel, A, et al.
Published: (2010)

Management of malignant pleural effusion
by: McCracken, D, et al.
Published: (2018)

The palliation of malignant pleural effusions.
by: Bhatnagar, R, et al.
Published: (2012)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion.
by: Morel, A, et al.
Published: (2011)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion
by: Morel, A, et al.
Published: (2011)

Is mesothelioma associated with increased risk of indwelling pleural catheter-related spetiated plueral effusion?
by: Asciak, R, et al.
Published: (2018)

Modern management of malignant pleural effusions
by: Mercer, R, et al.
Published: (2016)

Investigating suspected malignant pleural effusion.
by: Rahman, N, et al.
Published: (2007)

Malignant pleural effusions: management options
by: McCracken, DJ, et al.
Published: (2019)

Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma.
by: Adams, R, et al.
Published: (2001)

Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma
by: Adams, R, et al.
Published: (2001)

Novel mouse model of indwelling pleural catheter in mice with malignant pleural effusion
by: Merrick, C, et al.
Published: (2019)

Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.
by: Olfert, J, et al.
Published: (2016)

Patient derived pleural mesothelioma cell lines, can be used as tools, to guide patient stratification
by: Kanellakis, NI, et al.
Published: (2019)

Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion.
by: Penz, E, et al.
Published: (2014)

The relationship of pleural manometry with postthoracentesis chest radiographic findings in malignant pleural effusion
by: Chopra, A, et al.
Published: (2019)

THE USE OF INDWELLING PLEURAL CATHETERS FOR THE MANAGEMENT OF NON-MALIGNANT RECURRENT PLEURAL EFFUSIONS
by: Bhatnagar, R, et al.
Published: (2012)

Contemporary approach to the diagnosis of malignant pleural effusion
by: Kaul, V, et al.
Published: (2019)

Malignant pleural effusion: From diagnostics to therapeutics.
by: Asciak, R, et al.
Published: (2017)